References
Burnet M. Cancer. a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br Med J 1957;1:841–7.
Varade J, Magadan S, Gonzalez-Fernandez A. Human immunology and immunotherapy: main achievements and challenges. Cell Mol Immunol. 2021;18:805–28.
Speiser DE, Chijioke O, Schaeuble K, Munz C. CD4(+) T cells in cancer. Nat Cancer. 2023;4:317–29.
Zou W. Immune regulation in the tumor microenvironment and its relevance in cancer therapy. Cell Mol Immunol. 2022;19:1–2.
Ueda N, Zhang R, Tatsumi M, Liu TY, Kitayama S, Yasui Y, et al. BCR-ABL-specific CD4(+) T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells. Cell Mol Immunol. 2018;15:15–26.
Danelli L, Cornish G, Merkenschlager J, Kassiotis G. Default polyfunctional T helper 1 response to ample signal 1 alone. Cell Mol Immunol. 2021;18:1809–22.
Zou D, Yin Z, Yi SG, Wang G, Guo Y, Xiao X, et al. CD4(+) T cell immunity is dependent on an intrinsic stem-like program. Nat Immunol. 2024;25:66–76.
Kruse B, Buzzai AC, Shridhar N, Braun AD, Gellert S, Knauth K, et al. CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours. Nature. 2023;618:1033–40.
Quezada SA, Simpson TR, Peggs KS, Merghoub T, Vider J, Fan X, et al. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med. 2010;207:637–50.
Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. 2016;354:481–4.
Acknowledgements
This study received support from an internal fund provided by the Houston Methodist Research Institute (to W.C.). The authors would like to thank the Houston Methodist Flow Cytometry Core Facility for providing excellent services.
Author information
Authors and Affiliations
Contributions
DZ, XX, XCL and WC designed the study and wrote the manuscript. DZ performed the core experiments and data analysis. XZ, SL, NMG, and LJM supported the experimental work and data analysis. All the authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests. XCL is an editorial board member of Cellular & Molecular Immunology, but he has not been involved in the peer review or the decision-making of the article.
Supplementary information
Rights and permissions
About this article
Cite this article
Zou, D., Zhang, X., Li, S. et al. Aerobic glycolysis enables the effector differentiation potential of stem-like CD4+ T cells to combat cancer. Cell Mol Immunol 21, 527–529 (2024). https://doi.org/10.1038/s41423-024-01154-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-024-01154-w
- Springer Nature Limited